SENS
NASDAQ HealthcareSenseonics Holdings, Inc. - Common Stock
Medical Devices
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
�� 市场数据
| 价格 | $6.77 |
|---|---|
| 成交量 | 276,834 |
| 市值 | 283.01M |
| 贝塔系数 | 1.050 |
| RSI（14日） | 55.7 |
| 200日均线 | $7.82 |
| 50日均线 | $6.98 |
| 52周最高 | $15.74 |
| 52周最低 | $5.25 |
| Forward P/E | -2.57 |
| Price / Book | 4.58 |
🎯 投资策略评分
SENS 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🔪 Falling Knife (86/100) — 此策略 逆向投资（超卖 + 低于移动均线）.
评分最低的策略： 🐋 Institutional Whale (6/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 SENS in your text
粘贴任何文章、记录或帖子 — 工具将提取 SENS 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.